Štrauch, Branislav

Risk Factors for Nonadherence to Antihypertensive Treatment

Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C. M. J., Petrák, O., Gulsin, G. S., Patel, V., et al. (2017) · Hypertension

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 256

Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region

Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension

Hormonal Regulation and HypertensionRenin-Angiotensin System Studies

Cited by 237

Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence

Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Gulsin, G. S., Beech, A., Marešová, V., Topham, P. S., Stanley, A., et al. (2017) · Hypertension

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 194

Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study

Rosa, J., Widimský, P., Waldauf, P., Lambert, L., Zelinka, T., Táborský, M., Branny, M., Toušek, P., Petrák, O., Čurila, K., et al. (2016) · Hypertension

Blood Pressure and Hypertension StudiesHormonal Regulation and Hypertension

Cited by 78

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension

Hormonal Regulation and HypertensionAdrenal and Paraganglionic Tumors

Cited by 68